Publications by Helvi Holm Samdal
33 publications found
Original articles
Helicobacter pylori in early childhood and asthma in adolescence
BMC Res Notes, 13 (1), 79
DOI 10.1186/s13104-020-04941-6, PubMed 32070394
Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway
BMC Infect Dis, 15, 64
DOI 10.1186/s12879-015-0803-5, PubMed 25887603
Toxoplasma prevalence among pregnant women in Norway: a cross-sectional study
APMIS, 123 (4), 321-5
DOI 10.1111/apm.12354, PubMed 25628065
Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women
J Med Virol, 86 (5), 820-6
DOI 10.1002/jmv.23757, PubMed 24114849
[Dramatic case report caused by a rare bacteria]
Tidsskr Nor Laegeforen, 130 (2), 149-51
DOI 10.4045/tidsskr.08.0715, PubMed 20125205
Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts
Eur J Clin Microbiol Infect Dis, 27 (6), 461-5
DOI 10.1007/s10096-008-0460-3, PubMed 18293018
Seroprevalence of measles among Norwegian military conscripts in 2004
Eur J Clin Microbiol Infect Dis, 26 (3), 217-20
DOI 10.1007/s10096-007-0258-8, PubMed 17273828
Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity
Scand J Immunol, 63 (3), 223-31
DOI 10.1111/j.1365-3083.2006.01730.x, PubMed 16499576
Immunoglobulin-A antibodies in upper airway secretions may inhibit intranasal influenza virus replication in mice but not protect against clinical illness
Scand J Immunol, 61 (6), 503-10
DOI 10.1111/j.1365-3083.2005.01627.x, PubMed 15963044
A non-living nasal influenza vaccine can induce major humoral and cellular immune responses in humans without the need for adjuvants
Hum Vaccin, 1 (2), 85-90
DOI 10.4161/hv.1.2.1718, PubMed 17038826
Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae
Med Oncol, 19 (2), 71-8
DOI 10.1385/MO:19:2:71, PubMed 12180483
Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines
Bone Marrow Transplant, 28 (7), 681-7
DOI 10.1038/sj.bmt.1703228, PubMed 11704791
Human T-cell lymphotropic virus testing of blood donors in Norway: a cost-effect model
Int J Epidemiol, 29 (6), 1076-84
DOI 10.1093/ije/29.6.1076, PubMed 11101551
[Hepatitis C virus among pregnant women in Norway--occurrence of antibodies and pregnancy outcome]
Tidsskr Nor Laegeforen, 120 (9), 1006-8
PubMed 10833956
[HTLV examination of Norwegian blood donors]
Tidsskr Nor Laegeforen, 119 (2), 206-8
PubMed 10081351
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study
Scand J Gastroenterol, 32 (12), 1256-60
DOI 10.3109/00365529709028156, PubMed 9438325
The impact of exposure group on the progression rate to acquired immunodeficiency syndrome. A comparison between intravenous drug users, homosexual men and heterosexually infected subjects
Scand J Infect Dis, 29 (2), 103-9
DOI 10.3109/00365549709035868, PubMed 9181643
Comparison of the sensitivity of four rapid assays for the detection of antibodies to HIV-1/HIV-2 during seroconversion
Clin Diagn Virol, 7 (1), 55-61
DOI 10.1016/s0928-0197(96)00244-9, PubMed 9077430
Co-infection with HIV-1/HTLV-II and the risk of progression to AIDS and death. The Oslo HIV Cohort Study Group
APMIS, 104 (9), 666-72
DOI 10.1111/j.1699-0463.1996.tb04927.x, PubMed 8972691
Maternal human immunodeficiency virus infection and pregnancy outcome
Cent Afr J Med, 42 (8), 233-5
PubMed 8990567
[Quality adjusted life years in assessment of preventive measures. Should blood donors be tested for HTLV-I/II infections?]
Tidsskr Nor Laegeforen, 116 (10), 1229-32
PubMed 8658396
[Human T-cell lymphotrophic virus type I and T-cell lymphoma]
Tidsskr Nor Laegeforen, 116 (2), 238-41
PubMed 8633332
Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes
J Virol, 69 (2), 621-32
DOI 10.1128/JVI.69.2.621-632.1995, PubMed 7815525
Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin
N Engl J Med, 331 (24), 1607-11
DOI 10.1056/NEJM199412153312402, PubMed 7526215
[Risk of AIDS in the Oslo HIV-cohort study. A comparison between homosexual men, intravenous addicts and heterosexual persons]
Tidsskr Nor Laegeforen, 114 (24), 2831-4
PubMed 7998028
Diagnosis of infection with human T-lymphotropic virus type II (HTLV-II) in Norwegian HIV-infected individuals
Clin Diagn Virol, 1 (3), 143-52
DOI 10.1016/0928-0197(93)90009-t, PubMed 15566728
[Silent HIV infection in HIV seronegative persons]
Tidsskr Nor Laegeforen, 110 (1), 66-7
PubMed 2300943
Antibody dependent cell mediated cytotoxicity against anti-D sensitized human erythrocytes. Influence of various effector cells and enzyme treatment of the target cells
APMIS, 96 (3), 250-6
DOI 10.1111/j.1699-0463.1988.tb05298.x, PubMed 3126786
[Mycoplasma pneumoniae infections. A laboratory material]
Tidsskr Nor Laegeforen, 102 (15), 853-6
PubMed 7157264
Review articles
[Hepatitis C virus infection among pregnant women and their children in Norway]
Tidsskr Nor Laegeforen, 120 (9), 1047-50
PubMed 10833965
[Should pregnant women be tested for antibodies against hepatitis C virus?]
Tidsskr Nor Laegeforen, 120 (9), 1067-9
PubMed 10833968
Other articles
[Evaluate the HIV test correctly!]
Tidsskr Nor Laegeforen, 112 (7), 927
PubMed 1557769
Books
HIV strategimøte 6.november 1997: forelesningsmanuskripter og sammendrag med anbefalinger
Statens institutt for folkehelse, Oslo, 76 s.
BIBSYS 060383208, ISBN 82-7364-114-7